Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-06 04:37:24 - browse：9

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： How the BIOSECURE Act is already affecting U.S., Chinese life science firms

knowledge

WSS

Cheap, fast test for Zika and dengue could cost just $1

EQRx, failed developer of low

5 takeaways from STAT's examination of Zynex Medical

What to expect as Trump is arraigned on his Jan 6. indictment

Amazon expands telehealth clinic nationwide

California wildfire smoke linked to 52,000 early deaths, study says

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Trump indictment: Who are the 'co

Wildfire smoke exposes gaps in outdoor worker protections

NIH launches clinical trials and new research office for long Covid

In Memoriam: Notable people who died in 2023

Medical device trials still don't enroll enough women, study finds

In Memoriam: Notable people who died in 2023

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Sports medicine is finally prioritizing gender equality

Infectious disease expert Jeanne Marrazzo assumes Fauci role

explore

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

5 important ways Henrietta Lacks changed medical science

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Moderna says combo Covid

Breakthrough Alzheimer’s drugs are inaccessible in rural states

knowledge

leisure time

focus

explore